Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Zatosetron

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Zatosetron
Clinical data
ATC code
  • none
Identifiers
  • 5-chloro-2,2-dimethyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1-benzofuran-7-carboxamide
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC19H25ClN2O2
Molar mass348.87 g·mol−1
3D model (JSmol)
  • CC1(Cc2cc(cc(c2O1)C(=O)N[C@H]3C[C@H]4CC[C@@H](C3)N4C)Cl)C
  • InChI=1S/C19H25ClN2O2/c1-19(2)10-11-6-12(20)7-16(17(11)24-19)18(23)21-13-8-14-4-5-15(9-13)22(14)3/h6-7,13-15H,4-5,8-10H2,1-3H3,(H,21,23)/t13-,14+,15-
  • Key:SPKBYQZELVEOLL-QDMKHBRRSA-N
 ☒NcheckY (what is this?)  (verify)

Zatosetron (LY-277,359) is a drug which acts as anantagonist at the5HT3receptor[1] It is orally active and has a long duration of action, producingantinauseant effects but without stimulating the rate of gastrointestinal transport.[2][3] It is also an effectiveanxiolytic in both animal studies and human trials,[4] although with some side effects at higher doses.[5][6]

See also

[edit]

References

[edit]
  1. ^Cohen ML, Bloomquist W, Gidda JS, Lacefield W (July 1990). "LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity".The Journal of Pharmacology and Experimental Therapeutics.254 (1):350–5.PMID 2366187.
  2. ^Robertson DW, Lacefield WB, Bloomquist W, Pfeifer W, Simon RL, Cohen ML (January 1992). "Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships".Journal of Medicinal Chemistry.35 (2):310–9.doi:10.1021/jm00080a016.PMID 1732548.
  3. ^Schwartz SM, Goldberg MJ, Gidda JS, Cerimele BJ (March 1994). "Effect of zatosetron on ipecac-induced emesis in dogs and healthy men".Journal of Clinical Pharmacology.34 (3):250–4.doi:10.1002/j.1552-4604.1994.tb03994.x.PMID 7517409.S2CID 23486859.
  4. ^Smith WT, Londborg PD, Blomgren SL, Tollefson GD, Sayler ME (April 1999). "Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxiety".Journal of Clinical Psychopharmacology.19 (2):125–31.doi:10.1097/00004714-199904000-00006.PMID 10211913.
  5. ^Williams PD, Calligaro DO, Colbert WE, Helton DR, Shetler T, Turk JA, Jordan WH (March 1991). "General pharmacology of a new potent 5-hydroxytryptamine antagonist".Arzneimittel-Forschung.41 (3):189–95.PMID 1867653.
  6. ^Bendele A, Means J, Shoufler J, Schmalz C, Hanasono G, Symanowski J, Adams E (February 1995). "Chronic toxicity of zatosetron, a 5-HT3 receptor antagonist, in rhesus monkeys".Drug and Chemical Toxicology.18 (1):61–82.doi:10.3109/01480549509017858.PMID 7768200.
5-HT1ARTooltip 5-HT1A receptoragonists
GABAARTooltip GABAA receptorPAMsTooltip positive allosteric modulators
Gabapentinoids
(α2δVDCCblockers)
Antidepressants
Sympatholytics
(Antiadrenergics)
Others
5-HT3 serotonin ion
channel antagonists
5-HT serotonin G-protein
receptor antagonists
CB1agonists
(cannabinoids)
D2/D3 antagonists
H1 antagonists
(antihistamines)
mAChantagonists
(anticholinergics)
NK1 antagonists
Others
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Receptor
(ligands)
GlyRTooltip Glycine receptor
NMDARTooltip N-Methyl-D-aspartate receptor
Transporter
(blockers)
GlyT1Tooltip Glycine transporter 1
GlyT2Tooltip Glycine transporter 2
Stub icon

Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it.

Stub icon

This article about ananxiolytic is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Zatosetron&oldid=1248807766"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp